EKF Diagnostics Releases Educational Guide to Good Capillary

The global POC blood glucose monitoring devices market is expected toreach USD 2.03 billion in 2022, driven mainly by public and private initiativesto reduce diabetic cases. However, the high cost associated with diabetesmanagement is one of the major factors hindering the market growth.

These are the latest findings of Research and Markets, (Dublin, Ireland),a global market research company.

Most POC blood glucose monitoring devices manufactured by global and localplayers are cost-efficient. However, the cost associated with diabetesmanagement in high, resulting in out-of-pocket expenditure for consumables usedin POC blood glucose monitoring devices. These consumables, including bloodglucose test strips, reagents, and cassettes are expensive and are required ona daily basis. Moreover, an invasive device such as lancet needs to bepurchased separately along with the POC blood monitoring devices, resulting in additional cost being incurred.

Of late, there has been a paradigm shift to non-invasive products in thePOC blood glucose monitoring devices market. Non-invasive POC blood glucosemonitoring devices are hand-held units that offer a number of benefits overfinger prick glucose test, such as helping to avoid finger prick and providinga convenient, easy to read large number display. Non-invasive POC blood glucosemonitoring devices can also track patient compliance and allow multiple teststo be run in order to allow healthcare providers to provide adequatetherapeutic decisions.